Difference between revisions of "File:Fig4 Smith PracLabMed2024 InPress.jpg"

From LIMSWiki
Jump to navigationJump to search
 
(Added summary.)
 
Line 1: Line 1:
==Summary==
{{Information
|Description='''Figure 4.''' Anticipated response to the proposed rule. Respondents were asked how they think their laboratories would respond to the new regulatory requirements regarding their existing LDTs if the FDA adopts the proposed rule.
|Source={{cite journal |title=The US FDA’s proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing |journal=Practical Laboratory Medicine |author=Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R. |volume=In press |at=e00407 |year=2024 |doi=10.1016/j.plabm.2024.e00407}}
|Author=Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R.
|Date=2024
|Permission=[http://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International]
}}


== Licensing ==
== Licensing ==
{{cc-by-nc-nd-4.0}}
{{cc-by-nc-nd-4.0}}

Latest revision as of 20:15, 26 May 2024

Summary

Description

Figure 4. Anticipated response to the proposed rule. Respondents were asked how they think their laboratories would respond to the new regulatory requirements regarding their existing LDTs if the FDA adopts the proposed rule.

Source

Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R. (2024). "The US FDA’s proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing". Practical Laboratory Medicine In press: e00407. doi:10.1016/j.plabm.2024.e00407. 

Date

2024

Author

Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R.

Permission
(Reusing this file)

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

Other versions


Licensing

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current20:14, 26 May 2024Thumbnail for version as of 20:14, 26 May 20242,764 × 1,217 (178 KB)Shawndouglas (talk | contribs)

Metadata